Evidence map›Paper›PMID 21731485›Full record

ArticlePLoS pathogens2011

Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses.

Read Pukkila-Worley, Frederick M Ausubel, Eleftherios Mylonakis

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Novel infection byInfection and immunity · 2026
    Article
  3. Article
  4. Article
  5. Chelerythrine enhances anti-fungi immunity inFrontiers in immunology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. MultiplebioRxiv : the preprint server for biology · 2023
    Article
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Read Pukkila-WorleyDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Frederick M Ausubel
Eleftherios Mylonakis
Harvard University · USMassachusetts General Hospital · US

Funding

INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
SYSTEMIC AND EPITHELIAL INSECT IMMUNITYP01AI044220 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HOFFMAN, JULES A · 1998 to 2008
$10.8M
Studies of Caenorhabditis elegans innate immunityR01AI064332 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI AUSUBEL, FREDERICK M · 2005 to 2009
$2.1M
A C.elegans high-throughput assay for the identification of new antifungal agentsR01AI075286 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MYLONAKIS, ELEFTHERIOS · 2008 to 2010
$1.3M
Innate Immune Recognition of Candida albicans Infection in a C. elegans ModelK08AI081747 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PUKKILA-WORLEY, READ · 2010 to 2014
$684k
Genome-wide investigations in fungal pathogens utilizing an invertebrate model hoR21AI079569 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MYLONAKIS, ELEFTHERIOS · 2009 to 2010
$484k
NIAID NIH HHS AI044220NIAID NIH HHS AI064332NIAID NIH HHS AI075286NIAID NIH HHS AI079569NIAID NIH HHS AI081747NIAID NIH HHS K08 AI081747NIAID NIH HHS P01 AI044220NIAID NIH HHS R01 AI064332NIAID NIH HHS R01 AI075286NIAID NIH HHS R21 AI079569NIAID NIH HHS T32 AI007061
6 · The paper itself

Abstract

Candida albicans yeast cells are found in the intestine of most humans, yet this opportunist can invade host tissues and cause life-threatening infections in susceptible individuals. To better understand the host factors that underlie susceptibility to candidiasis, we developed a new model to study antifungal innate immunity. We demonstrate that the yeast form of C. albicans establishes an intestinal infection in Caenorhabditis elegans, whereas heat-killed yeast are avirulent. Genome-wide, transcription-profiling analysis of C. elegans infected with C. albicans yeast showed that exposure to C. albicans stimulated a rapid host response involving 313 genes (124 upregulated and 189 downregulated, ~1.6% of the genome) many of which encode antimicrobial, secreted or detoxification proteins. Interestingly, the host genes affected by C. albicans exposure overlapped only to a small extent with the distinct transcriptional responses to the pathogenic bacteria Pseudomonas aeruginosa or Staphylococcus aureus, indicating that there is a high degree of immune specificity toward different bacterial species and C. albicans. Furthermore, genes induced by P. aeruginosa and S. aureus were strongly over-represented among the genes downregulated during C. albicans infection, suggesting that in response to fungal pathogens, nematodes selectively repress the transcription of antibacterial immune effectors. A similar phenomenon is well known in the plant immune response, but has not been described previously in metazoans. Finally, 56% of the genes induced by live C. albicans were also upregulated by heat-killed yeast. These data suggest that a large part of the transcriptional response to C. albicans is mediated through "pattern recognition," an ancient immune surveillance mechanism able to detect conserved microbial molecules (so-called pathogen-associated molecular patterns or PAMPs). This study provides new information on the evolution and regulation of the innate immune response to divergent pathogens and demonstrates that nematodes selectively mount specific antifungal defenses at the expense of antibacterial responses.

Indexed as

AnimalsBiological EvolutionCaenorhabditis elegansCandida albicansFungiGene Expression ProfilingGene Expression Regulation, FungalGenes, BacterialGenes, FungalImmunity, InnatePseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID21731485
PMCPMC3121877
OpenAlexW2001689516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.